FLT3 and Myelodysplasia: In 2022, the European LeukemiaNet (ELN) risk classification system for acute myeloid leukemia patients modified risk genes including CEBPA mutation status, myelodysplasia‐related gene mutations and internal tandem duplications of FLT3 (FLT3‐ITD).